Category: Myelin Repair

Myelin Repair Foundation Grants License for Novel Mouse Model to Biogen Idec

MRF’s Innovative Technology Can Accelerate Drug Research and Development for Multiple Sclerosis SARATOGA, Calif.–(BUSINESS WIRE)–Jul. 1, 2013– The Myelin Repair Foundation (MRF)…

Stuart Schlossman

Stem Cells Hold Potential to Repair Immune Responses in MS Patients (Video)

Mesenchymal stem cells (green) accumulate in skeletal muscle following exercise and release growth factors to spur regeneration. (Photo : Marni…

Stuart Schlossman

New imaging technique holds promise for speeding MS research

Media Release | June 12, 2013 Researchers at the University of British Columbia have developed a new magnetic resonance imaging…

Stuart Schlossman

Big Multiple Sclerosis Breakthrough Reduced 50-75% of bad immune system activity while leaving a normal immune system

 A phase 1 clinical trial for the first treatment to reset the immune system of multiple sclerosis  JUNE 10, 2013…

Stuart Schlossman

Medical breakthrough for multiple sclerosis

Medical breakthrough for multiple sclerosis sufferers By Amanda Woerner Published June 06, 2013 FoxNews.com In a breakthrough discovery, researchers have discovered…

Stuart Schlossman

Promoting Remyelination in Multiple Sclerosis

By Shaheen E Lakhan, MD, PhD, MEd, MS  The Mayo Clinic and Acorda recently enrolled the first patient in their phase…

Stuart Schlossman

Fluorescent proteins light up the where and when of autoimmune disease (MS)

T LYMPHOCYTES APRIL 30, 2013 BY: LORI FRIEND *above photograph: (at top) A T lymphocyte is activated after contact with a…

Stuart Schlossman

Mayo Clinic and Acorda Therapeutics Announce Initiation of Phase 1 Trial of Remyelinating Antibody in People with Multiple Sclerosis

Discovered at Mayo Clinic, rHIgM22 Represents Potential New Approach to MS Treatment ROCHESTER, Minn. & ARDSLEY, N.Y.–(BUSINESS WIRE)– Apr. 23,…

Stuart Schlossman

Fog Lifting in MS Gender Enigma

Information provided by: Cherie C. Binns RN BS MSCN This report is part of a 12-month Clinical Context series. By Kathleen…

Stuart Schlossman

Stem Cell Therapy for Patients With Multiple Sclerosis Failing Interferon A Randomized Study – at Northwestern University

This study is currently recruiting participants. Verified December 2012 by Northwestern University Sponsor: Richard Burt, MD Collaborators: Rush University Medical Center…

Stuart Schlossman

Categories

Latest Blog Posts